Home RYTM
28.32
  Price4.89%   +1.32
(After Hours: 27.56 -0.76 -2.68%)
loading

Rhythm Pharmaceuticals (RYTM) Latest News

Nov-08-22 08:25AM Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research
07:05AM Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Clinical Trial of IMCIVREE® (setmelanotide) in Bardet-Biedl Syndrome in The Lancet Diabetes and EndocrinologyGlobeNewswire Inc.
Nov-02-22 07:30AM Rhythm Pharmaceuticals Presents Data from Phase 2 and Long-term Extension Trials Evaluating Setmelanotide for the Treatment of Hypothalamic Obesity at ObesityWeek® and Plans to Initiate Phase 3 Trial in Early 2023GlobeNewswire Inc.
Oct-26-22 10:02AM Earnings Preview: Solid Biosciences Inc. (SLDB) Q3 Earnings Expected to DeclineZacks Investment Research
Oct-25-22 10:02AM Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q3 Earnings Expected to DeclineZacks Investment Research
Sep-23-22 08:00AM Rhythm Pharmaceuticals Announces Publication of Children’s Book for Patients and Families Living with Bardet-Biedl Syndrome (BBS)GlobeNewswire Inc.
Sep-19-22 04:01AM Rhythm Pharmaceuticals, Inc. Announces Closing of $124.8 Million Public OfferingGlobeNewswire Inc.
Sep-16-22 04:38AM Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From YesterdayBenzinga
Sep-15-22 01:03AM Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day SessionBenzinga
07:55AM Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving PremarketBenzinga
Sep-15-22 06:23AM Arconic, Rhythm Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market SessionBenzinga
05:21AM Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From YesterdayBenzinga
Sep-15-22 02:47AM Twilio, AMTD Digital And Other Big Gainers From WednesdayBenzinga
Sep-14-22 10:20AM Rhythm Pharmaceuticals, Inc. Announces Pricing of Public OfferingGlobeNewswire Inc.
04:01AM Rhythm Pharmaceuticals, Inc. Announces Proposed Public OfferingGlobeNewswire Inc.
Sep-13-22 05:14AM Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From YesterdayBenzinga
Sep-09-22 04:13AM Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From YesterdayBenzinga
Sep-08-22 01:11AM Expert Ratings for Rhythm PharmaceuticalsBenzinga
12:15PM Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day SessionBenzinga
Sep-08-22 10:42AM AeroVironment, Snap And Some Other Big Stocks Moving Higher On ThursdayBenzinga
Sep-07-22 04:01AM Rhythm Pharmaceuticals Announces New Employment Inducement GrantsGlobeNewswire Inc.
Aug-28-22 09:29AM 3 Healthcare Stocks That Are Beating the MarketThe Motley Fool
Aug-25-22 01:12AM Annovis Bio (ANVS) Begins Dosing in Phase III Parkinson's StudyZacks Investment Research
11:53AM Akero Therapeutics (AKRO) Up on Positive NASH Study DataZacks Investment Research
Aug-25-22 10:15AM What Bear Market? These 3 Stocks Have Been Rocketing Higher in 2022The Motley Fool
Aug-23-22 12:42PM bluebird (BLUE) Up 101% in the Past Three Months: Here's WhyZacks Investment Research
Aug-22-22 12:28PM Aeglea BioTherapeutics (AGLE) Seeks EU Nod for ARG1-D TreatmentZacks Investment Research
Aug-16-22 03:28AM This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From YesterdayBenzinga
Aug-15-22 12:05PM Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day SessionBenzinga
Aug-12-22 09:55AM After Golden Cross, Rhythm Pharmaceuticals, Inc. (RYTM)'s Technical Outlook is BrightZacks Investment Research
Aug-08-22 11:33AM Why Goldman Sachs Raised Its Price Target On This Biotech Stock By Nearly 5XBenzinga
10:10AM Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022Benzinga
Aug-05-22 10:43AM Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022Benzinga
Aug-04-22 05:54AM This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From YesterdayBenzinga
04:00AM Moderna, PayPal And Some Other Big Gainers From WednesdayBenzinga
Aug-03-22 01:22AM What 7 Analyst Ratings Have To Say About Rhythm PharmaceuticalsBenzinga
08:00AM Rhythm Pharmaceuticals to Present at Canaccord Genuity 42nd Annual Growth ConferenceGlobeNewswire Inc.
Aug-03-22 06:07AM Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From YesterdayBenzinga
Jun-16-22 04:02AM Rhythm Pharmaceuticals Enters into a Non-dilutive Revenue Interest Financing Agreement with HealthCare Royalty for up to $100 MillionGlobeNewswire Inc.
04:01AM Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Use in Patients with Bardet-Biedl SyndromeGlobeNewswire Inc.
Rhythm Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of peptide therapeutics for the treatment of rare genetic disorders of obesity in the United States. Its peptide candidates include Setmelanotide, a melanocortin-4 receptor agonist, which is in Phase III clinical trial to treat POMC and leptin receptor deficiency obesity; and Phase II clinical trial for Bardet-Biedl and Alström syndrome, POMC heterozygous deficiency obesity, and POMC epigenetic disorders. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. Rhythm Pharmaceuticals, Inc. is a subsidiary of Motus Therapeutics, Inc.
Cap:    |  Volume (24h):